Networks

The FMP participates in numerous collaborative projects in Berlin and throughout Germany. The current projects are listed here.

Clusters of Excellence

• EXC 2008: UniSysCat (Website)
  - with Dorothea Fiedler, Adam Lange and Han Sun
• EXC 2049: NeuroCure (Website)
  - with Volker Haucke, Thomas Jentsch and Noa Lipstein

Research Units

• FOR 2518: Functional dynamics of ion channels and transporters - DynIon - (Website)
  - with Han Sun
• FOR 2625: Mechanisms of Lysosomal Homeostasis (Website)
  - with Thomas Jentsch and Volker Haucke
• FOR 5228: Membrane trafficking processes underlying presynaptic proteostasis
  - with Volker Haucke

Collaborative Research Centres

• SFB 958: Scaffolding of Membranes: Molecular Mechanisms and Cellular Functions (Website)
  - with Volker Haucke, Michael Krauß and Fan Liu
• SFB 1078: Protonation Dynamics in Protein Function (Website)
  - with Han Sun, Adam Lange and Hartmut Oschkinat
• SFB 1286: Quantitative Synaptology (Website)
  - with Noa Lipstein
• SFB 1365: Renoprotection (Website)
  - with Thomas Jentsch
• SFB 1449: Dynamic Hydrogels at Biointerfaces
  - with Christian Hackenberger

Transregios

• TRR 186: Molecular Switches: Spatio-temporal Control of Cellular Signal Transmission (Website)
  - with Volker Haucke and Dorothea Fiedler

Research Training Groups

• GRK 2318: TJ-Train - Tight junctions and their proteins: molecular features and actions in health and disease (Website)
  - with Volker Haucke
• GRK 2473: SynPepBio - Bioactive Peptides – Innovative Aspects of Synthesis and Biosynthesis (Website)
  - with Christian Hackenberger

Healthy Aging (Website)
This Leibniz Research Alliance is interested in the question if a healthy lifestyle promotes cognitive performance in old age.

Bioactive Compounds and Biotechnology (Website)
This Leibniz Research Alliance combines 20 Leibniz Institutes that research the most varied aspects of molecules with biological effects.

The Helmholtz Health Research Centres decided in 2011 to support a joint drug research initiative and allocated a significant budget for its necessary resources. FMP with its very successful and renowned compound screening facility is a prominent partner in this initiative. Through this partnership MDC supports the upgrading of the FMP-platform to a full Chemical Biology Unit, that is able to more comprehensively carry projects from early discovery up to a qualified tool compound.

Read more about the Helmholtz Joint Drug Research Initiative here.